Asia-Pacific RNAi Drug Delivery Market By Drug Delivery (pulmonary Drug Delivery Technology, Aptamer Drug Delivery Technology, Nucleic Acid Drug Delivery Technology And Nanoparticle Drug Delivery Technology), By Therapeutic Application (cardiology, Metabolic Disorders, Oncology, Ophthalmology, Infectious Diseases And Neurology), And By Region – Industry Analysis, Share, Size, Growth, Trends, And Forecasts (2018-2023).

Asia-Pacific RNAi Drug Delivery Market By Drug Delivery (pulmonary Drug Delivery Technology, Aptamer Drug Delivery Technology, Nucleic Acid Drug Delivery Technology And Nanoparticle Drug Delivery Technology), By Therapeutic Application (cardiology, Metabolic Disorders, Oncology, Ophthalmology, Infectious Diseases And Neurology), And By Region – Industry Analysis, Share, Size, Growth, Trends, And Forecasts (2018-2023).

ID: 1979 | Pages: 138 | April 2018 | Region: Asia Pacific


Overview of the Market:
Asia-Pacific RNAi Drug Delivery Market has been estimated at USD 7.49 billion in 2018 and is projected to reach USD 26.76 billion by 2023, at a CAGR of 29% during the forecast period from 2018-2023. RNA interference is a process in which RNA inhibits the gene expression, by degrading mRNA molecules. It is also called Gene silencing. Recently, we are sending artificial drugs to carry out these functions and that process is called RNAi Drug Delivery.

The growth of this method is started from last 15 years before that this method was applied only to the plants. Right now, Researchers are doing various types of experiments to minimize the side effects of drugs and to invent new types of drugs.

Few factors like Increasing incidence of chronic diseases like cancer and cardiovascular diseases, and innovative Applications of drug delivery market are driving this market. In addition, Research carried out in RNA Therapeutic field has also fueled the growth in Asia Pacific RNA Drug Delivery Market. But, High investments and stringent Regulations are some of the major restraints to this market. Targeted Delivery of RNAi Drugs is the key challenge faced by the market. Increasing investments by key players of this market is driving this market’s growth.

Asia-Pacific RNAi Drug Delivery market is segmented based on Drug Delivery and Therapeutic Application. Based on Drug Delivery, this market is further segmented into pulmonary drug delivery technology, aptamer drug delivery technology, nucleic acid drug delivery technology and nanoparticle drug delivery technology. Based on Therapeutic Application, the market is further segmented into cardiology, metabolic disorders, oncology, ophthalmology, infectious diseases and neurology.

Geographical Analysis: 
Based on Geography, this market is further segmented in to India, China, Japan, Australia and South Korea. This region has the highest CAGR because of increased investments by key players in this region.

Key Players in this Market: 
Key players in this region are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Access Pharmaceuticals Inc., Sirnaomics Inc., Isis Pharmaceuticals Inc, RXi Pharmaceuticals Corp., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Marina Biotech Inc., Tacere Therapeutics Inc., and PhaseRx Inc.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Drug delivery                                             

                                5.1.1 Introduction                           

                                5.1.2 nanoparticle drug delivery technology                        

                                5.1.3 pulmonary drug delivery technology                           

                                5.1.4 nucleic acid drug delivery technology                          

                                5.1.5  aptamer drug delivery technology                               

                                5.1.6  Y-o-Y Growth Analysis, By Drug Delivery                   

                                5.1.7  Market Attractiveness Analysis, By Drug delivery                 

                                5.1.8 Market Share Analysis, By drug Delivery                    

                5.2 Therapeutic Application                                        

                                5.2.1 Introduction                           

                                5.2.2 infectious diseases                              

                                5.2.3 cardiology                

                                5.2.4 oncology                  

                                5.2.5 neurology                

                                5.2.6 ophthalmology                      

                                5.2.7 metabolic disorders                            

                                5.2.8  Y-o-Y Growth Analysis, By Therapeutic Application                              

                                5.2.9  Market Attractiveness Analysis, By Therapeutic Application                            

                                5.2.10 Market Share Analysis, By Therapeutic Application                             

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Drug Delivery               

                                                6.1.3.3 By Therapeutic Application           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Drug Delivery               

                                                6.1.4.3 By Therapeutic Application           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Drug Delivery               

                                                6.1.5.3 By Therapeutic Application           

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Alnylam Pharmaceuticals Inc.                                             

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Merck & Co. Inc                                        

                8.3 Access Pharmaceuticals Inc.                                

                8.4 Dicerna Pharmaceuticals Inc.                                              

                8.5 Tekmira Pharmaceuticals Corp.                                          

                8.6 Isis Pharmaceuticals Inc                                         

                8.7 Calondo Pharmaceuticals Inc.                                             

                8.8 Marina Biotech Inc.                                 

                8.9 RXi Pharmaceuticals Corp                                     

                8.10 Quark Pharmaceuticals Inc                                

                8.11 Silence Therapeutics plc                                     

                8.12 Traversa Therapeutics Inc.                                 

                8.13 Tacere Therapeutics Inc                                      

                8.14 Sirnaomics Inc.                                        

                8.15 PhaseRx Inc.                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  2. Asia-Pacific nanoparticle drug delivery technology Market By Region, From 2018-2023 ( USD Billion )
  3. Asia-Pacific pulmonary drug delivery technology Market By Region, From 2018-2023 ( USD Billion )
  4. Asia-Pacific nucleic acid drug delivery technology  Market By Region, From 2018-2023 ( USD Billion )
  5. Asia-Pacific aptamer drug delivery technology Market By Region, From 2018-2023 ( USD Billion )
  6. Asia-Pacific RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
  7. Asia-Pacific infectious diseases Market By Region, From 2018-2023 ( USD Billion )
  8. Asia-Pacific cardiology Market By Region, From 2018-2023 ( USD Billion )
  9. Asia-Pacific oncology Market By Region, From 2018-2023 ( USD Billion )
  10. Asia-Pacific neurology Market By Region, From 2018-2023 ( USD Billion )
  11. Asia-Pacific ophthalmology Market By Region, From 2018-2023 ( USD Billion )
  12. Asia-Pacific metabolic disorders Market By Region, From 2018-2023 ( USD Billion )
  13. Japan RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  14. Japan RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
  15. China RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  16. China RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
  17. India RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  18. India RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
  19. Australia RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  20. Australia RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
  21. South Korea RNAi Drug Delivery Market By Drug Delivery, From 2018-2023 ( USD Billion )
  22. South Korea RNAi Drug Delivery Market By Therapeutic Applications, From 2018-2023 ( USD Billion )
Middle East And Africa FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (...
Latin America FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (Diagnosti...
Asia Pacific FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (Diagnostic...
Europe FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (Diagnostic Labor...
North America FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (Diagnosti...
FISH Imaging Systems Market By Products (Microscopes, Instruments, Automated Cell Analyzers, Services), By Applications (Cancer Diagnosis, Genetic Disease Diagnosis And Others), By End Users (Diagnostic Laboratories...
The PET Scanners Market Is Predicted To Reach USD 1129 Million With A CAGR Of 3.15% According To Market Data Forecast Report....
Middle East And Africa PET Scanners Market By Application (Oncology, Neurology, Cardiology And Others), By Product Type (Partial Ring PET Scanners And Full Ring PET Scanners), By Detector Type (Gadolinium Oxyorthosi...
Latin America PET Scanners Market By Application (Oncology, Neurology, Cardiology And Others), By Product Type (Partial Ring PET Scanners And Full Ring PET Scanners), By Detector Type (Gadolinium Oxyorthosilicate, L...
Asia Pacific PET Scanners Market By Application (Oncology, Neurology, Cardiology And Others), By Product Type (Partial Ring PET Scanners And Full Ring PET Scanners), By Detector Type (Gadolinium Oxyorthosilicate, Lu...
Europe PET Scanners Market By Application (Oncology, Neurology, Cardiology And Others), By Product Type (Partial Ring PET Scanners And Full Ring PET Scanners), By Detector Type (Gadolinium Oxyorthosilicate, Lutetium...
North America PET Scanners Market By Application (Oncology, Neurology, Cardiology And Others), By Product Type (Partial Ring PET Scanners And Full Ring PET Scanners), By Detector Type (Gadolinium Oxyorthosilicate, L...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.